Status:
COMPLETED
Calprotectin I Serum as a Diagnostic Marker
Lead Sponsor:
St. Olavs Hospital
Collaborating Sponsors:
Norwegian University of Science and Technology
Conditions:
Pulmonary Disease, Chronic Obstructive
Eligibility:
All Genders
18+ years
Brief Summary
Lower respiratory tract infection is the most common cause of acute exacerbations of chronic obstructive pulmonary disease (AECOPD). Patients diagnosed with pneumonia in addition to an AECOPD experien...
Eligibility Criteria
Inclusion
- clinically confirmed acute exacerbation of chronic obstructive pulmonary disorder (AECOPD)
- COPD diagnosis previously confirmed by spirometry according to the GOLD criteria.
Exclusion
- known malignant disease
- bronchiectasis
- chronic bacterial colonisation of the airways
- treatment with an immunosuppressive drug or long-term treatment with antibiotics.
- not examined with a chest X-ray at admission
Key Trial Info
Start Date :
April 3 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 14 2018
Estimated Enrollment :
113 Patients enrolled
Trial Details
Trial ID
NCT03474484
Start Date
April 3 2018
End Date
September 14 2018
Last Update
September 21 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Thoracic and Occupational Medicine
Trondheim, Trøndelag, Norway, 7006